Catalyst Wire Dossier Catalyst Wire Dossier

Elivaldogene Autotemcel

elivaldogene autotemcel · Genetix Biotherapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elivaldogene Autotemcel, covering 2025-07-02 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

See pricing